Lung, Breast, GI cancers and well as Leukemia/Lymphoma, psychology
Drexel University School of Medicine, Philadelphia, PA
University of Washington, Seattle, WA
Internal Medicine, University of Washington, Seattle, WA
Hematology/Oncology, University of California - San Francisco, San Francisco, CA
Awards & Achievements
Outstanding Graduate Student Award
Resident Excellence in Teaching Award
1st Place, Academic Research Competition, Naval Medical Center, San Diego
Naval Medical Center, San Diego Admiral's Letter of Appreciation
Meritorious Service Medal
Meritorious Unit Commendation
National Defense Service Medal
Global War on Terrorism Service Medal
Navy and Marine Corps Overseas Service Medal
Afghanistan Campaign Medal
Lukas J, Groshen S, Saffari B, Wen W, Reles A, Niu N, Felix J, Jones L, Hall FL, Press MF. The p21WAF1/CIP1 Gene Polymorphism and Expression in Carcinomas of the Breast, Ovary and Endometrium. American Journal of Pathology 150: 167-175, 1997.
Tsang J-L, Zhao Y, Lukas J, Yang X, Shah A, Press M, Shibata D. Telomerase Activity in Normal and Neoplastic Breast. Clinical Cancer Research 3: 627-631, 1997.
Karlyn K, Lukas J, De Francisco J, Brahmbhatt D, Friedman M, Neal R, Smillie L, Shriner K. Changing Highly Active Antiretroviral Therapy (HAART) and its Effects on Viral Load (VL) and CD4 Count. International Conference on AIDS Proceedings 12: 365-368, 1998.
Yang XW, Uziely B, Groshen S, Lukas J, Israel V, Russell C, Dunnington G, Formenti S, Muggia F, and Press MF. MDR1 Gene Expression in Primary and Advanced Breast Cancer. Laboratory Investigation 79: 271-280, 1999.
Lukas J, Niu N, Press MF. p53 Mutations and Expression in Breast Carcinoma in Situ. American Journal of Pathology 156: 183-191, 2000.
Schmider A, Gee C, Friedmann W, Lukas J, Press MF, Lichtenegger W, Reles A. p21 (WAF1/Cip1) Protein Expression is Associated with Prolonged Survival but not with p53 Expression in Epithelial Ovarian Carcinoma. Gynecologic Oncology 77: 237-242, 2000.
Lukas J, Gao D-Q, Keshmeshian M, Wen W-H, Tsao-Wei D, Rosenberg S, Press MF. Alternative and Aberrant Messenger RNA Splicing of the mdm2 Oncogene in Invasive Breast Cancer. Cancer Research 61: 3212-3219, 2001.
Blakely WF, Miller AC, Luo L, Lukas J, Hornby ZD, Hamel CJC, Nelson JT, Escalada NE, Prasanna PGS. Nucleic Acid Molecular Biomarkers for Diagnostic Biodosimetry Applications: Use of the Fluorogenic 5'-nuclease Polymerase Chain Reaction Assay. Military Medicine 167: 16-19, 2002.
Knutson KL, Dang Y, Lu H, Lukas JJ, Almand B, Gad E, Azeke E and Disis ML: IL-2 immunotoxin therapy modulates tumor associated regulatory T cells and leads to lasting immune mediated rejection of breast cancers in neu-transgenic mice. Journal of Immunology 177: 84-91, 2006.
Listerman I, Sun J, Gazzaniga FS, Lukas JJ, Blackburn EH: The Major Reverse Transcriptase–Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis. Cancer Research 73: 2817–2828, 2013.
American Society of Clinical Oncology